Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study
We found no evidence of age group differences in SARS-CoV-2 seroprevalence, particularly for ethnic minority groups, even when accounting for exposure and susceptibility. While early prevention strategies particularly aimed at protecting older adults against SARS-CoV-2 infections, seroprevalence was similar across age groups in ethnic minority groups. Thus, older adults in ethnic minority groups may pose a target group for additional prevention strategies for future infectious disease outbreaks.
Authors
- Anders C. Boyd (ORCID: https://orcid.org/0000-0001-9512-8928)
- Liza Coyer (ORCID: https://orcid.org/0000-0001-5830-2982)
- Annemieke M. W. Spijkerman
- Renee Bolijn (ORCID: https://orcid.org/0000-0002-0803-6118)
- Maria Prins (ORCID: https://orcid.org/0000-0003-2967-0289)
- Henrike Galenkamp (ORCID: https://orcid.org/0000-0002-5904-3465)
- Karien Stronks (ORCID: https://orcid.org/0000-0002-0921-2232)
- Anneke Blokstra
Institutions
- National Institute for Public Health and the Environment (NL)
- Stichting HIV Monitoring (NL)
- GGD Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1371/journal.pone.0311196
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- ZonMw
- Hartstichting
- Rijksinstituut voor Volksgezondheid en Milieu